← SynDRA
LETERMOVIR
SynDRA canonical compound SYN0024474 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Mechanism of action | CMV terminase inhibitor |
|---|
| Indication | cytomegalovirus (CMV) |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- CMV terminase inhibitor
- Inhibitor
- TRM1 INHIBITOR
- TRM2 INHIBITOR
- TRM3 INHIBITOR
Drug classes
- Anti-Infective Agents
- Antineoplastic Agents
- Antiviral Agents
- Enzyme Inhibitors
- Poly(ADP-ribose) Polymerase Inhibitors
- Cytochrome P450 2C9 Inducers
- Cytochrome P450 2C19 Inducers
- Cytochrome P450 2C8 Inhibitors
- Organic Anion Transporting Polypeptide 1B1 Inhibitors
- Organic Anion Transporting Polypeptide 1B3 Inhibitors
- Cytochrome P450 3A Inhibitors
- Cytomegalovirus DNA Terminase Complex Inhibitor
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- prevymis
- AIC246
- AIC-246
- MK-8228
- Prevymis
- 1H09Y5WO1F
- AIC 246
- letermovirum
- RefChem:57199
- DTXCID90161174
- J05AX18
- MFCD22572725
- Letermovir [INN]
- Letermovir [USAN:INN]
- UNII-1H09Y5WO1F
- Prevymis (TN)
- Letermovir (Standard)
- Letermovir(AIC246)
- LETERMOVIR [MI]
- LETERMOVIR [JAN]
- LETERMOVIR [USAN]
- Letermovir(AIC-246)?
- LETERMOVIR [WHO-DD]
- Letermovir (JAN/USAN/INN)
- SCHEMBL379403
- orb1301825
- LETERMOVIR [ORANGE BOOK]
- SCHEMBL29367234
- SCHEMBL29438348
- C29H28F4N4O4
- EX-A1871
- BDBM50614677
- EBC-27337
- HY-15233R
- s8873
- AKOS030526995
- CS-1571
- NCGC00378936-01
Reported adverse events
Look up LETERMOVIR in the interactive SynDRA portal →